NM_015656.2:c.830G>A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_015656.2(KIF26A):​c.830G>A​(p.Arg277His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000175 in 1,608,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

KIF26A
NM_015656.2 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -0.465

Publications

2 publications found
Variant links:
Genes affected
KIF26A (HGNC:20226): (kinesin family member 26A) Predicted to enable microtubule binding activity and microtubule motor activity. Predicted to be involved in enteric nervous system development; negative regulation of signal transduction; and regulation of cell growth by extracellular stimulus. Predicted to be located in cytosol. Predicted to be part of kinesin complex. Predicted to be active in microtubule. [provided by Alliance of Genome Resources, Apr 2022]
KIF26A Gene-Disease associations (from GenCC):
  • cortical dysplasia, complex, with other brain malformations 11
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Baylor College of Medicine Research Center

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11140466).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000177 (27/152168) while in subpopulation NFE AF = 0.000235 (16/67994). AF 95% confidence interval is 0.000147. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF26ANM_015656.2 linkc.830G>A p.Arg277His missense_variant Exon 4 of 15 ENST00000423312.7 NP_056471.1 Q9ULI4
KIF26AXM_011536641.3 linkc.-5+5388G>A intron_variant Intron 1 of 11 XP_011534943.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF26AENST00000423312.7 linkc.830G>A p.Arg277His missense_variant Exon 4 of 15 5 NM_015656.2 ENSP00000388241.2 Q9ULI4
KIF26AENST00000315264.7 linkc.413G>A p.Arg138His missense_variant Exon 3 of 14 1 ENSP00000325452.7 C9JFF0
KIF26AENST00000697132.1 linkc.926G>A p.Arg309His missense_variant Exon 4 of 15 ENSP00000513129.1 A0A8V8TM02

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152168
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000131
AC:
31
AN:
236184
AF XY:
0.000146
show subpopulations
Gnomad AFR exome
AF:
0.000212
Gnomad AMR exome
AF:
0.0000590
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000478
Gnomad NFE exome
AF:
0.000221
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000174
AC:
254
AN:
1456318
Hom.:
0
Cov.:
32
AF XY:
0.000167
AC XY:
121
AN XY:
724140
show subpopulations
African (AFR)
AF:
0.000330
AC:
11
AN:
33336
American (AMR)
AF:
0.0000676
AC:
3
AN:
44396
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25974
East Asian (EAS)
AF:
0.0000759
AC:
3
AN:
39506
South Asian (SAS)
AF:
0.0000466
AC:
4
AN:
85900
European-Finnish (FIN)
AF:
0.0000773
AC:
4
AN:
51770
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5750
European-Non Finnish (NFE)
AF:
0.000202
AC:
224
AN:
1109666
Other (OTH)
AF:
0.0000833
AC:
5
AN:
60020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152168
Hom.:
0
Cov.:
33
AF XY:
0.000121
AC XY:
9
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41460
American (AMR)
AF:
0.0000654
AC:
1
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
67994
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000849
Hom.:
0
Bravo
AF:
0.000170
ESP6500AA
AF:
0.000256
AC:
1
ESP6500EA
AF:
0.000243
AC:
2
ExAC
AF:
0.000150
AC:
18

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 10, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.830G>A (p.R277H) alteration is located in exon 4 (coding exon 4) of the KIF26A gene. This alteration results from a G to A substitution at nucleotide position 830, causing the arginine (R) at amino acid position 277 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Jul 01, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.014
.;T
Eigen
Benign
-0.99
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.053
N
LIST_S2
Benign
0.74
T;T
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
1.9
L;.
PhyloP100
-0.47
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-0.56
N;N
REVEL
Benign
0.095
Sift
Uncertain
0.019
D;D
Sift4G
Benign
0.093
T;T
Polyphen
0.024
B;.
Vest4
0.28
MVP
0.82
MPC
0.16
ClinPred
0.017
T
GERP RS
0.025
Varity_R
0.026
gMVP
0.23
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200160417; hg19: chr14-104624186; COSMIC: COSV59464629; API